Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).
2025 · 1st Quarter (Jan 1 - Mar 31)
ACADIA PHARMACEUTICALS
Filed by ACADIA PHARMACEUTICALS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 18, 2025
- Income
- Not reported
- Expenses
- $440,000.00
- Registrant
- ACADIA PHARMACEUTICALS
- Client
- ACADIA PHARMACEUTICALS
- Filing UUID
- bec4e0ed-f1a4-4cc0-9bf8-f5b4afe265a6
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492).
Cameron's Law (HR 14114)
Literal federal measure citations: HR 14114
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.